Journal
BIOORGANIC CHEMISTRY
Volume 124, Issue -, Pages -Publisher
ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.bioorg.2022.105813
Keywords
Dihydrotriazine derivatives; ROS levels; Autophagosomes; Anticancer agents
Funding
- Natural Science Foundation of Jilin Province [20210502028ZP]
- Department of Education of Jilin Province [JJKH20210495KJ]
- Zhoushan Science and Technology Bureau [2021C31044]
Ask authors/readers for more resources
A series of dihydrotriazine derivatives bearing 5-aryloxypyrazole moieties were designed and their anticancer activities were explored. Compound 10e exhibited the most potent antiproliferative activity against HepG-2 cells and induced autophagy and apoptosis. Further studies revealed enhanced expression of key proteins and autophagosome formation.
A series of dihydrotriazine derivatives bearing 5-aryloxypyrazole moieties were designed, and their anticancer activities against three human cancer cell lines (SGC-7901, HepG-2 and MCF-7) and one non-cancer cell line (LO2) were explored using the MTT assay in vitro. Most of the compounds exhibited potent antiproliferative activities against the three cancer cell lines, with compound 10(e) (IC50 = 2.12 mu M) exhibiting the most potent antiproliferative activity against HepG-2 cells. Interestingly, autophagy was observed in the 10e-treated HepG-2 cells. Compound 10e also increased reactive oxygen species (ROS) levels and resulted in marked HepG-2 cells apoptosis. Further studies revealed that compound 10e could enhance the expression of Cl-PARP, Cl-caspase-3, and Cl-caspase-9. In addition, 10e triggered the formation of autophagosomes by promoting LC3-II and Beclin-1 expression. These results might be useful for exploring and developing dihydrotriazine derivatives as novel anticancer agents.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available